ZNO Stock Overview
Engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Zoono Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.026 |
| 52 Week High | AU$0.13 |
| 52 Week Low | AU$0.024 |
| Beta | 0.44 |
| 11 Month Change | -10.34% |
| 3 Month Change | -78.33% |
| 1 Year Change | -27.78% |
| 33 Year Change | -96.10% |
| 5 Year Change | -72.34% |
| Change since IPO | -87.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZNO | AU Chemicals | AU Market | |
|---|---|---|---|
| 7D | 4.0% | 1.1% | -0.3% |
| 1Y | -27.8% | 0.4% | 8.3% |
Return vs Industry: ZNO underperformed the Australian Chemicals industry which returned 1% over the past year.
Return vs Market: ZNO underperformed the Australian Market which returned 8.3% over the past year.
Price Volatility
| ZNO volatility | |
|---|---|
| ZNO Average Weekly Movement | 23.8% |
| Chemicals Industry Average Movement | 10.9% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in AU Market | 16.3% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: ZNO's share price has been volatile over the past 3 months.
Volatility Over Time: ZNO's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | n/a | zoono.com |
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company’s products include hand sanitizers, textile applicators, mould remediation, and surface sanitizers. It serves airlines, healthcare, childcare, facilities management, transportation, education, and hospitality sectors.
Zoono Group Limited Fundamentals Summary
| ZNO fundamental statistics | |
|---|---|
| Market cap | AU$8.83m |
| Earnings (TTM) | -AU$7.00m |
| Revenue (TTM) | AU$1.95m |
4.5x
P/S Ratio-1.3x
P/E RatioIs ZNO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZNO income statement (TTM) | |
|---|---|
| Revenue | NZ$2.14m |
| Cost of Revenue | NZ$4.52m |
| Gross Profit | -NZ$2.39m |
| Other Expenses | NZ$5.26m |
| Earnings | -NZ$7.65m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.022 |
| Gross Margin | -111.72% |
| Net Profit Margin | -358.17% |
| Debt/Equity Ratio | 9.6% |
How did ZNO perform over the long term?
See historical performance and comparison